CJ Cheiljedang Corporation (KRX:097955)
South Korea · Delayed Price · Currency is KRW | Market Cap | 2.70T -25.0% |
| Revenue (ttm) | 28.39T +8.3% |
| Net Income | -632.15B |
| EPS | -39,446.80 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 7.34 |
| Dividend | 6,050.00 (5.98%) |
| Ex-Dividend Date | Nov 27, 2026 |
| Volume | 2,734 |
| Open | 101,700 |
| Previous Close | 100,500 |
| Day's Range | 100,400 - 102,700 |
| 52-Week Range | 98,500 - 144,200 |
| Beta | 0.12 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 10, 2026 |
About CJ Cheiljedang
CJ Cheiljedang Corporation engages in the food business in South Korea and internationally. It operates through Food, Biotechnology, Feed and Care, and Logistics segments. The company offers home meal replacement, meat/fishery processing, seasoning/sauce, sweetener/flour/oil, and seaweed/dessert/snack/beverage products. It also provides amino acid, green protein, enzyme, plant nutrition and health, and specialty solution; biopolymer solution; and polyhydroxyalkanoate products. In addition, the company offers taste and nutrition solutions. Furth... [Read more]
Financial Performance
Financial StatementsNews
CJ Cheiljedang Earnings Call Transcript: Q3 2026
Q3 sales grew across food, Technical Solution, and Performance Ingredients, but consolidated operating profit fell with CJ Logistics included. Q4 guidance calls for low-single-digit sales growth excluding logistics and an operating margin in the 5% range.
CJ Cheiljedang Slides: Q3 2026
CJ Cheiljedang has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on November 9, 2026.
South Korea's CJ CheilJedang And ADM Form JV For Feed Amino Acids
(RTTNews) - South Korean food and biotech company CJ CheilJedang Corp. (097950.KS) and ADM (ADM), announced Friday they have agreed to form a new joint venture to secure a reliable, long-term source o...
CJ Cheiljedang Earnings Call Transcript: Q2 2026
Q2 2026 saw strong sales growth in global food and BIO, but profitability was pressured by higher costs, FX losses, and strategic investments. A major business reorganization aims to drive future competitiveness, with Q3 sales and margins expected to improve year-over-year.
CJ Cheiljedang Slides: Q2 2026
CJ Cheiljedang has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 10, 2026.
CJ Cheiljedang Quarterly report: Q2 2026
CJ Cheiljedang has published its Q2 2026 quarterly earnings report on August 10, 2026.
CJ Cheiljedang Q1 Operating Profit Declines
(RTTNews) - CJ Cheiljedang Corporation (097950.KS) reported first quarter net income attributable to shareholders of the parent company of 81.83 billion Korean won, a substantial increase of 363.8% co...
CJ Cheiljedang Earnings Call Transcript: Q1 2026
Q1 2026 saw sales growth across food, BIO, and logistics, but operating profit declined due to BIO price pressures. Q2 is expected to bring improved profitability, especially in BIO, with continued sales growth and margin recovery amid ongoing global expansion and cost challenges.
CJ Cheiljedang Slides: Q1 2026
CJ Cheiljedang has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 11, 2026.
CJ Cheiljedang Quarterly report: Q1 2026
CJ Cheiljedang has published its Q1 2026 quarterly earnings report on May 11, 2026.
CJ Cheiljedang Earnings Call Transcript: Q4 2025
Q4 2025 saw modest sales growth but a sharp drop in operating profit due to Bio business weakness and holiday timing. Global Food outperformed, while Bio faced intense competition and pricing pressure. 2026 guidance projects low single-digit sales growth and stable margins.
CJ Cheiljedang Annual report: Q4 2025
CJ Cheiljedang has published its Q4 2025 annual report on February 9, 2026.
CJ Cheiljedang Slides: Q4 2025
CJ Cheiljedang has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 9, 2026.